445 related articles for article (PubMed ID: 34183017)
21. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome.
Wang X; Li B; Liu L; Zhang L; Ma T; Guo L
Int Immunopharmacol; 2021 Jan; 90():107092. PubMed ID: 33290962
[TBL] [Abstract][Full Text] [Related]
22. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
23. Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis.
Abdullah A; Maged M; Hairul-Islam M I; Osama I A; Maha H; Manal A; Hamza H
PLoS One; 2019; 14(4):e0215981. PubMed ID: 31026283
[TBL] [Abstract][Full Text] [Related]
24. A novel PADRE-Kv1.3 vaccine effectively induces therapeutic antibodies and ameliorates experimental autoimmune encephalomyelitis in rats.
Fan C; Long R; You Y; Wang J; Yang X; Huang S; Sheng Y; Peng X; Liu H; Wang Z; Liu K
Clin Immunol; 2018 Aug; 193():98-109. PubMed ID: 29496642
[TBL] [Abstract][Full Text] [Related]
25. Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
Thomé R; de Carvalho AC; Alves da Costa T; Ishikawa LL; Fraga-Silva TF; Sartori A; de Oliveira AL; Verinaud L
CNS Neurosci Ther; 2016 Aug; 22(8):707-14. PubMed ID: 27165523
[TBL] [Abstract][Full Text] [Related]
26. The kinetics of myelin antigen uptake by myeloid cells in the central nervous system during experimental autoimmune encephalomyelitis.
Sosa RA; Murphey C; Ji N; Cardona AE; Forsthuber TG
J Immunol; 2013 Dec; 191(12):5848-57. PubMed ID: 24227784
[TBL] [Abstract][Full Text] [Related]
27. Alteration of the cytokine signature by various TLR ligands in different T cell populations in MOG37-50 and MOG35-55-induced EAE in C57BL/6 mice.
Steckner C; Weber A; Mausberg AK; Heininger M; Opdenhövel F; Kieseier BC; Hartung HP; Hofstetter HH
Clin Immunol; 2016 Sep; 170():22-30. PubMed ID: 27233983
[TBL] [Abstract][Full Text] [Related]
28. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic effect of the total saponin from Panax Japonicus on experimental autoimmune encephalomyelitis by attenuating inflammation and regulating gut microbiota in mice.
Wang J; He L; Wang S; Zhao H; Chen J; Dong Y; Yasen S; Wang L; Zou H
J Ethnopharmacol; 2023 Oct; 315():116681. PubMed ID: 37230280
[TBL] [Abstract][Full Text] [Related]
30. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
31. Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice.
Zarzecki MS; Cattelan Souza L; Giacomeli R; Silva MRP; Prigol M; Boeira SP; Jesse CR
Neurochem Res; 2020 Dec; 45(12):2959-2977. PubMed ID: 33040279
[TBL] [Abstract][Full Text] [Related]
32. High Dimensional Cytometry of Central Nervous System Leukocytes During Neuroinflammation.
Mrdjen D; Hartmann FJ; Becher B
Methods Mol Biol; 2017; 1559():321-332. PubMed ID: 28063054
[TBL] [Abstract][Full Text] [Related]
33. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.
Moransard M; Bednar M; Frei K; Gassmann M; Ogunshola OO
J Neuroinflammation; 2017 Oct; 14(1):202. PubMed ID: 29029628
[TBL] [Abstract][Full Text] [Related]
34. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
Front Immunol; 2019; 10():2436. PubMed ID: 31681316
[TBL] [Abstract][Full Text] [Related]
35. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK
J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177
[TBL] [Abstract][Full Text] [Related]
36. Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation.
Garcia JA; Pino PA; Mizutani M; Cardona SM; Charo IF; Ransohoff RM; Forsthuber TG; Cardona AE
J Immunol; 2013 Aug; 191(3):1063-72. PubMed ID: 23817416
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
[TBL] [Abstract][Full Text] [Related]
38. Notch signaling regulates T cell accumulation and function in the central nervous system during experimental autoimmune encephalomyelitis.
Sandy AR; Stoolman J; Malott K; Pongtornpipat P; Segal BM; Maillard I
J Immunol; 2013 Aug; 191(4):1606-13. PubMed ID: 23825310
[TBL] [Abstract][Full Text] [Related]
39. Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG
Wetzel LA; Hurtado M; MacDowell Kaswan ZA; McCusker RH; Steelman AJ
Brain Behav Immun Health; 2020 Aug; 7():100116. PubMed ID: 34589873
[TBL] [Abstract][Full Text] [Related]
40. Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis.
Das Sarma J; Ciric B; Marek R; Sadhukhan S; Caruso ML; Shafagh J; Fitzgerald DC; Shindler KS; Rostami A
J Neuroinflammation; 2009 Apr; 6():14. PubMed ID: 19400960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
